Shire PLC (LON:SHP)‘s stock had its “overweight” rating reaffirmed by JPMorgan Chase & Co. in a research report issued to clients and investors on Monday.

Several other analysts have also commented on SHP. Royal Bank Of Canada reaffirmed an “outperform” rating on shares of Shire PLC in a report on Wednesday, June 15th. Jefferies Group raised their target price on Shire PLC from GBX 6,050 ($78.97) to GBX 6,600 ($86.15) and gave the stock a “buy” rating in a report on Wednesday, August 3rd. BNP Paribas reaffirmed an “outperform” rating and set a GBX 5,700 ($74.40) target price on shares of Shire PLC in a report on Monday, June 6th. Shore Capital reaffirmed a “buy” rating on shares of Shire PLC in a report on Tuesday, June 14th. Finally, Deutsche Bank AG reaffirmed a “buy” rating and set a GBX 6,000 ($78.32) target price on shares of Shire PLC in a report on Monday, September 19th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, sixteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of GBX 5,828 ($76.07).

Analyst Recommendations for Shire PLC (LON:SHP)

Shire PLC (LON:SHP) opened at 4997.602539 on Monday. The stock’s 50 day moving average price is GBX 4,983.22 and its 200 day moving average price is GBX 4,511.67. The company’s market cap is GBX 34.12 billion. Shire PLC has a 52-week low of GBX 2,707.19 and a 52-week high of GBX 5,377.00.

The firm also recently announced a dividend, which will be paid on Friday, October 7th. Shareholders of record on Thursday, September 8th will be paid a dividend of GBX 3.51 ($0.05) per share. The ex-dividend date of this dividend is Thursday, September 8th. This represents a yield of 0.07%.

In other Shire PLC news, insider Dominic Blakemore bought 133 shares of the business’s stock in a transaction on Friday, September 30th. The stock was bought at an average price of GBX 5,010 ($65.40) per share, with a total value of £6,663.30 ($8,697.69).

Shire PLC Company Profile

Shire plc is a biotech company. The Company, along with its subsidiaries, is engaged in developing and marketing medicines for patients with rare diseases and other select conditions. The Company operates in the segment of research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines.

Receive News & Stock Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related stocks with our FREE daily email newsletter.